Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone and finasteride improve muscle strength and size after spinal cord injury.

Dermatologists vary widely in testing practices for alopecia areata, often exceeding guideline recommendations.

A fast and accurate method was developed to measure alfuzosin and dutasteride in human plasma.

Both fluoxetine and clomipramine effectively treat dog lick dermatitis, but fluoxetine works faster with lower recurrence, while clomipramine has fewer side effects.

AMT® shows promise as a safe and effective treatment for early-stage knee osteoarthritis.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

Using fractional CO2 laser with halometasone cream works better for chronic hand eczema than just the cream, improving symptoms and quality of life with fewer relapses.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

PRP is a promising alternative for alopecia areata due to its safety and patient satisfaction.

Low-level red light therapy can shorten eye length in some myopic children.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Oral baricitinib is effective and safe for treating alopecia areata.

The combination therapy was effective and well-tolerated, especially in young patients.

Many patients in the rheumatology clinic adjusted or stopped their medications due to side effects.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

Nearly half of the classification tools in the National Institute of Health and Clinical Excellence's Clinical Knowledge Summaries might not effectively guide management for general practitioners.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.